We also found that the levels of total HSP27 were significantly upregulated in tumors treated with cisplatin (CIS) or combination therapy with cisplatin and perhexiline (CIS + PER) compared to vehicle control tumors (Figure 6A). The gene discussed is HSPB1; the disease is in situ carcinoma.